Skip to content

MSLE - Satellos Bioscience Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchM

Satellos Bioscience Inc. Common Stock

MSLE · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

M

MSLESatellos Bioscience Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $13.39
52-wk low: $5.14
Prev close: $8.83
Mkt cap: $214.1M
Beta: 1.17
P/B: 3.5x

Smart money

4 funds hold a position.

Real smart money

Funds holding this stock

4 holders

Combined position$7.0M

P7
Point72
Steven Cohen · Q2 2026 13F
$5.3M
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Reported Aug 12, 2026

Earnings came in 47.4% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $214M

Valuation

P/B3.48

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: MSLE
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $214.07M
Beta: 1.17

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-70.5%

$1.2M

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$527K

position

1 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 1 holders

Coverage gaps for MSLE

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.56-47.4%

-$0.38 expected

Next report

What the street expects next

EPS expected

-$0.52

-$0.60 to -$0.44

Revenue expected

$0.00

5 analysts

Last 30 days

1up1down

Split both ways

Estimate drift

+0.16

Change in 30 days

-70.5%

ROA-41.9%

Growth

Beta1.17